🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, global, double-blind, 2-arm randomized study designed ...
Status
Completed
Location
St. Joseph'S Hospital & Medical Center
Start Date
2017-03-08
Trial ID
NCT03038100
Treatments Being Tested
This is a multicenter, double-blind, placebo-controlled, randomized, phase ...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2021-12-01
Trial ID
NCT04308785
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Status
Completed
Location
UCLA
Start Date
2020-12-15
Trial ID
NCT04619797
This three-cohort, multi-stage, randomized, Phase II, multicenter trial wil...
Status
Terminated
Location
Cancer Specialists of North Florida
Start Date
2015-03-12
Trial ID
NCT02322814
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of atezoli...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2020-10-30
Trial ID
NCT04540211
The purpose of the study is to evaluate the efficacy and safety of tiragolu...
Status
Completed
Location
Rocky Mountain Cancer Center - Denver
Start Date
2020-03-04
Trial ID
NCT04294810
Treatments Being Tested
This study will evaluate the efficacy and safety of atezolizumab when given...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2020-04-09
Trial ID
NCT04194203
Treatments Being Tested
This is a global Phase III, double-blind, randomized, placebo-controlled st...
Status
Completed
Location
Stanford University Medical Center
Start Date
2017-07-24
Trial ID
NCT03197935
The purpose of this study is to evaluate the efficacy and safety of tiragol...
Status
Active Not Recruiting
Location
Florida Cancer Specialists - Fort Myers (Broadway)
Start Date
2020-09-28
Trial ID
NCT04543617
Treatments Being Tested
This Phase 3, multicenter, randomized, double-blind, placebo controlled stu...
Status
Completed
Location
Stanford Cancer Center
Start Date
2017-08-25
Trial ID
NCT03125902
Treatments Being Tested